Biodesix, Inc. (BDSX) vs Castle Biosciences, Inc. (CSTL)
- Biodesix, Inc. BDSX 23.66 −4.25%
- Castle Biosciences, Inc. CSTL 31.96 −5.44%
Biodesix, Inc. and Castle Biosciences, Inc. are both Diagnostics & Research companies. Castle Biosciences, Inc. is the larger, with a market value of $1.0B against $260.7M — 4.0× the size. Biodesix, Inc. grew revenue faster over the last twelve months: 34.5% against 3.18%. Castle Biosciences, Inc. has the higher net margin (−5.43% vs −27.0%) and the higher return on invested capital (−9.40% vs −49.6%). Across the 18 metrics below, Castle Biosciences, Inc. leads on 13 and Biodesix, Inc. on 5.
Valuation
Profitability
| Metric | BDSX | CSTL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 82.50% | 77.26% | 50.89% |
| Operating margin | (20.02%) | (8.99%) | (8.57%) |
| Net margin | (26.97%) | (5.43%) | (6.37%) |
| Free cash flow margin | (19.82%) | (0.13%) | 0.00% |
| Return on equity | (540.01%) | (4.20%) | (2.92%) |
| Return on assets | (30.33%) | (3.51%) | (6.71%) |
| Return on invested capital | (49.60%) | (9.40%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack